Development of improved cholera vaccine based on subunit toxoid (original) (raw)

Nature volume 269, pages 602–604 (1977)Cite this article

Abstract

THE cholera vaccines now available consist of killed vibrios, and give rise to only limited protection of short duration1. The finding that the excessive diarrhoea in cholera is due to the action on the small intestine epithelium of an exotoxin produced by the vibrios2,3 has focused attention on the potential of toxoid for improved immunoprophylaxis. The development of a suitable toxoid has met with great difficulties, however. Formalin toxoid, although reasonably antigenic, proved unsatisfactory because of reversion to toxicity4. Glutaraldehyde toxoid was stable but poorly immunogenic which explains its low efficacy in a recent field trial5. We describe here the development and properties of a subunit cholera toxoid, the nature of which eliminates the risk of reversion to toxicity. The high protective immunogenicity observed in experimental animals gives promise that addition of this toxoid to the conventional vaccine will result in a significantly improved immunoprophylactic agent against cholera.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Finkelstein, R. A. Crit. Rev. Microbiol. 2, 553–623 (1973).
    Article CAS Google Scholar
  2. De, S. N. Nature 183, 1533–1534 (1959).
    Article CAS ADS Google Scholar
  3. Dutta, N. K., Panse, M. V. & Kulkarni, D. R. J. Bact. 78, 594–595 (1959).
    Article CAS Google Scholar
  4. Northrup, R. S. & Chisari, F. V. J. infect. Dis. 125, 672–673 (1972).
    Article CAS Google Scholar
  5. Curlin, G., Levine, R., Aziz, K. M. A., Rahman, M. A. S. M. & Verwey, W. F. Proc. 11th U.S.-Japan Cholera Conf. New Orleans November 1975, 314–329 (US Department of Health, Education and Welfare, Washington, 1975).
  6. Holmgren, J., Lönnroth, I. & Ouchterlony, Ö. Infect. Immun. 3, 747–755 (1971).
    Article CAS Google Scholar
  7. Lönnroth, I. & Holmgren, J. J. gen. Microbiol. 76, 417–427 (1973).
    Article Google Scholar
  8. Cuatrecasas, P., Parikh, I. & Hollenberg, M. D. Biochemistry 12, 4253–4263 (1973).
    Article CAS Google Scholar
  9. van Heyningen, S. Science 183, 656–657 (1974).
    Article CAS ADS Google Scholar
  10. Holmgren, J. & Lönnroth, I. J. gen. Microbiol. 86, 49–65 (1975).
    Article CAS Google Scholar
  11. Lai, C. Y., Mendez, E. & Chang, D. J. infect. Dis. 133, Suppl. S23–S30 (1976).
    Article Google Scholar
  12. Kurosky, A., Markel, D. E., Peterson, J. W. & Fitch, W. M. Science 195, 299–300 (1977).
    Article CAS ADS Google Scholar
  13. Holmgren, J. Proc. 9th U.S.-Japan Cholera Conf. Grand Canyon October 1973. US Department of State Publ. 8762, 196–213 (1973).
  14. Holmgren, J., Lindholm, L. & Lönnroth, I. J. exp. Med. 139, 801–819 (1974).
    Article CAS Google Scholar
  15. Holmgren, J. & Svennerholm, A. M. J. infect. Dis. 136, Suppl. August (1977).
  16. Finkelstein, R. A., Fujita, K. & LoSpalluto, J. J. J. Immun. 107, 1043–1051 (1971).
    CAS Google Scholar
  17. Craig, J. Nature 207, 614–616 (1965).
    Article CAS ADS Google Scholar
  18. Lönnroth, I. & Lönnroth, C. Expl Cell. Res. 104, 15–24 (1977).
    Article Google Scholar
  19. Hanson, L. Å., Holmgren, J. & Wadsworth, C. Int. Arch. Allergy appl. Immun. 40, 806–819 (1971).
    Article CAS Google Scholar
  20. Svennerholm, A. M. & Holmgren, J. Infect. Immun. 13, 735–740 (1976).
    Article CAS Google Scholar
  21. Rappaport, R. S., Bonde, G., McCann, T., Rubin, B. A. & Tint, H. Infect. Immun. 9, 304–317 (1974).
    Article CAS Google Scholar
  22. Holmgren, J. & Svennerholm, A. M. Infect. Immun. 7, 759–763 (1973).
    Article CAS Google Scholar
  23. Orskov, F. Orskov, I., Jann, K., Müller-Seitz, E. & Westphal, O. Acta pathol. microbiol. Scand. 71, 339–358 (1976).
    Article Google Scholar

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Microbiology, University of Göteborg, Sweden
    J. HOLMGREN, ANN-MARI SVENNERHOLM & I. LÖNNROTH
  2. National Bacteriological Laboratory, Stockholm, Sweden
    MARGARETA FALL-PERSSON, B. MARKMAN & H. LUNDBECK

Authors

  1. J. HOLMGREN
    You can also search for this author inPubMed Google Scholar
  2. ANN-MARI SVENNERHOLM
    You can also search for this author inPubMed Google Scholar
  3. I. LÖNNROTH
    You can also search for this author inPubMed Google Scholar
  4. B. MARKMAN
    You can also search for this author inPubMed Google Scholar
  5. H. LUNDBECK
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

HOLMGREN, J., SVENNERHOLM, AM., LÖNNROTH, I. et al. Development of improved cholera vaccine based on subunit toxoid.Nature 269, 602–604 (1977). https://doi.org/10.1038/269602a0

Download citation

This article is cited by